Logo

Veterinary Diagnostics

News on veterinary diagnostics and testing.

VolitionRx Bets on Canine Cancer Screening Test as Nucleosome Tech Development Continues
Premium

The company recently signed on Heska for selling its Nu.Q Vet Cancer Screening Test at the point of care, and Sage Healthcare as a distributor in Singapore.

One Health Company Using Dog Models to Improve Targeted Cancer Therapy Development
Premium

In a recent study, company researchers and their collaborators found that tumors in dogs and humans share mutational hotspots in a number of cancer-related genes.

PetDx Raises $62M in Series B Round

The company plans to use the new funding in part to accelerate the rollout of its flagship OncoK9 liquid biopsy assay for detecting cancer in dogs.

Veterinary Startup PetDx Bets on Liquid Biopsy for Annual Cancer Screening in Dogs
Premium

The firm's panel test, which will initially cost $400, identifies genetic biomarkers linked to over 20 cancers in dogs using cell-free and genomic DNA from blood.

Boehringer Ingelheim, GNA Biosolutions Partner on African Swine Fever Dx

The firms are focusing on developing a rapid diagnostic test for African swine fever that can be used on GNA's portable MDx platform.

Breaking News
The Scan

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.